26 - 28 October 2020

Program

The MedTech20 Virtual Conference will feature international and local presenters speaking on the key issues affecting MedTech. The program is subject to changes.

 

Welcome to MedTech2020

Day 1
13:00-13:20
Ian Burgess

Mr Ian Burgess

Chief Executive Officer
MTAA
 

The Perfect Storm: Getting Through COVID-19

Day 1
13:20-13:55
PaulD headshot BRC

Mr Paul Docherty

Founder
3DMEDiTech
Michelle Stewart

Ms Michelle Stewart

General Manager, Marketing & Digital
Device Technologies
Jefferson Harcourt-2020

Mr Jefferson Harcourt

Executive Chair
Grey Innovation
Arnett, Annie sq

Annie Arnett

Vice President & General Manager
Hologic Inc.
James Doyle Photo

Mr James Doyle

Senior Director, Commercial & Public Affairs
Strkyer
Rozalina S Health Industry Hub

Rozalina Sarkezians

Managing Director
Health Industry Hub Media
 

Interview with Prof. John Skerritt of the TGA

Day 1
13:55-14:35
Discussion with Prof. John Skerritt, Deputy Secretary, Health Products Regulation Group, on the regulation of software as a Medical Device, regulatory changes over the past 12 months and future changes as well as the TGA’s handling of COVID response.
john skerritt

Adj. Prof. John Skerritt

Deputy Secretary, Health Products Regulation Group
TGA, Department of Health
George

Mr George Faithfull

Vice President, Government & Regulatory Affairs
Stryker
 

DRGs in the Private System – Options and Impacts

Day 1
14:35-15:25
Private Healthcare Australia (PHA), the Grattan Institute and the Independent Hospital Pricing Authority (IHPA) have all proposed that Diagnosis Related Group (DRG) funding models replace the Prostheses List to pay for prostheses through the private healthcare system. At this session PHA and the medical devices industry will go head to head on the pros and cons of this approach.
Dale, Paul Headshot

Mr Paul Dale

Director of Policy
MTAA
Ben Harris, Director of Policy and Research, PHA

Mr Ben Harris

Director of Policy and Research
PHA
Medtronics Conference

Ms Natalie Lawandi

Snr Manager, Healthcare Economics, Policy & Reimbursement
Medtronic
Kathy Ryan Headshot

Ms Cathy Ryan

Group Director, Health Funding & Patient Services
Cabrini Health
Rochelle Airey Headshot

Ms Rochelle Airey

Clinical Procurement Manager
St Vincent's Health Australia
 

Hon Karen Andrews MP Session

Day 1
15:25-15:45
MTP

MTPConnect

Keynote Session Sponsor
Karen Andrews Headshot v2

Hon Karen Andrews MP

Minister for Industry, Science and Technology
Australian Commonwealth Government
Dan Grant

Dr Dan Grant

Managing Director & CEO
MTPConnect
 

COVID-19 and the Global Supply Chain

Day 1
15:45-16:30
In the delivery of health care to Australians, MedTech companies are highly dependent on access to a well-functioning global supply chain to ensure that care can be delivered in a cost-effective and timely manner.  The majority of MedTech products are imported into Australia, and a thorough understanding of the factors impacting on the supply chain is critical to maintaining access to care for Australian patients. In this session our panel experts will discuss the global supply chain and the impact of COVID-19 on the supply of medical devices and the delivery of care to Australians.
Sue-Martin

Ms Susan Martin

Managing Director, Australia & New Zealand
Johnson & Johnson Medical
KW Headshot -- Approved for Internal and External

Ms Kathy Wengel

Executive Vice President & Chief Global Supply Chain Officer
Johnson & Johnson
Andrew Frye Headshot

Mr Andrew Frye

Senior Vice President & President, APAC
Baxter Healthcare, Chairman of APACMed
serge

Mr Serge Bernasconi

Chief Executive Officer
MedTech Europe
Maurice

Mr Maurice Ben-Mayor

President
Stryker South Pacific & Chairman, MTAA

27 October 2020

Day 2

 

Procurement Update - HealthShare NSW

Day 2
13:00-13:22
The CEO of Healthshare NSW will explain the key goals and direction for device procurement for the public sector in NSW into 2021 and beyond, including approaches to industry engagement, system change, and the relationship with other parts of NSW Health.
Carmen Rechbauer

Ms Carmen Rechbauer

Chief Executive Officer
Healthshare NSW
Dan Kildea

Mr Dan Kildea

Senior Government Affairs and Policy Manager
Johnson & Johnson
 

Latest developments in the Clinical Quality Registries Framework review

Day 2
13:22-13:54
Updates on the Framework running projects:
  • Evidence check: Governance, accreditation and quality assurance of CQRs
  • Quality standard: Guidance on governance arrangements for national CQRs
  • Updating existing National Health Information Arrangements
  • Developing CQR assessment criteria
There is enormous potential for Clinical Quality Registries (CQRs) to inform care delivery at the patient, clinician, local, national and international levels. CQRs data can be used to demonstrate safety and effectiveness of higher risk medical devices, potentially replacing lengthy premarket clinical trials. The Framework promotes best practice in design, development, operation and security of CQRs to facilitate efficiencies in the development of national clinical quality registry infrastructure in Australia. CQRs have the potential to report on retrospective, current and prospectively collected data to a wide range of stakeholders including clinicians, patients, hospital administrators, government, funders and insurers.
Headshot Natascha Millard

Ms Natascha Millard

Senior Clinical Research Manager
Stryker
Search Results Web results Australian Commission on Safety and Quality in Health Care

Dr. Bernadette Aliprandi-Costa

Safety & Quality Improvement Systems and Intergovernmental Relations
Australian Commission on Safety and Quality in Health Care
 

The Ethics of AI in Healthcare

Day 2
13:54-14:26
The use of Artificial Intelligence (AI) is rapidly advancing in every area of healthcare. It is influencing the data we collect, the technology we develop and the way we treat patients. So what does the future of AI look like and what are the ethical considerations now we have access to such advanced technology? As MedTech businesses continue to innovate let’s think about the processes that will need to be in place for our patients, technology and the future. Hear from a number of engaging speakers about current and emerging technologies and a vision of the future of AI in healthcare.
Headshot Terry Sweeney

Dr Terry Sweeney

Founder & Principal
Auxilia – Digital Health
Rogers cropped (002)

Prof. Wendy Rogers

Professor of Clinical Ethics
Macquarie University
Arnett, Annie sq

Ms Annie Arnett

Vice President & General Manager
Hologic Inc.
 

EU Medical Device Regulation and BREXIT Update

Day 2
14:26-15:10
The UK officially exited the EU on 31 January 2020. Under the Brexit agreement, UK notified bodies continue to be recognised for the transition period through to 31 December 2020. How will device manufacturers and sponsors manage approvals issued by UK notified bodies at the end of the transitional arrangements?

Due to the pressure on national health authorities and manufacturers and suppliers of medical devices to address COVID-19 priorities, the European Parliament has postponed the deadline for full enforcement of the MDR by one year to allow authorities and the medical device industry to prioritise the fight against the coronavirus pandemic. How will Australia remain aligned with EU MDR while managing new implementation timelines?
George

Mr George Faithfull

Vice President Government & Regulatory Affairs
Stryker
Tracey-Duffy

Ms Tracey Duffy

First Assistant Secretary, Health Product Quality Division
Department of Health
Headshot

Mr Jesús Rueda Rodríguez

Director International Affairs
MedTech Europe
Mr Oliver Bisazzo

Mr Oliver Bisazzo

Director Regulations & Industrial Policy
MedTech Europe
IMG

Mr Erik Hansson

Deputy Head of Unit, Directorate General for SANTE, Medical Devices and Health Technology Assessment
EU Commission
 

To Infinity and Beyond - MedTech Outside Hospital Walls

Day 2
15:10-15:50
High pressure and high-risk environments have influenced medical innovation throughout history. In 1917, we saw the introduction of a new method to facial reconstruction developed by New Zealand surgeon Harold Gillies. His treatment to the horrific facial injuries inflicted on soldiers during World War I led to the advancements in improved facial reconstruction techniques and the use of metal plates to help bring relief to many of his patients.

In this session, we will explore what is driving medical innovation today and are how they may find a way into a hospital near you.
pat williams

Mr Pat Williams

Managing Director ANZ
Edwards Lifesciences
Chris Dawson Headshot

Mr Chris Dawson

Director, Field Clinical Engineering
Presidio Medical Inc. (ex. NASA)
Glenn Keys Headshot.jpg

Mr Glenn Keys AO

Company Founder & Executive Chair
Aspen Medical
David Waters Headshot.jpg

Mr David Waters

Chief Executive Officer
The Council of Ambulance Authorities
MichaelReade

Prof. Michael Reade AM

Professor of Military Medicine & Surgery, University of Queensland and Australian Defence Force Joint Health Command; Brigadier,
Director General Health Reserve, Australian Army

28 October 2020

Day 3

 

Action under Adversity

Day 3
10:00-10:32
MTANZ CEO, Faye Sumner, will share her experience with national medical emergencies and Industry's response to three tragic events New Zealand encountered in recent years - The Christchurch terrorist attack, White Island eruption and the management of COVID-19.
Faye

Faye Sumner

Chief Executive Officer
Medical Technology Association of New Zealand (MTANZ)
 

Could Data be your Super Power?

Day 3
10:34-11:04
Concurrent session: Data is knowledge and knowledge is power
Data is everything, if used in the right way, business wide it can truly become your new Super Power. But are we using our data to the best of our ability and what does Super look like? Join us to understand how you can leverage your data and turn it into your new Super Power.
Headshot

Mr Salem Lassoued

Founder & Director
Data Organica
LizCarnabuci_Square FINAL

Ms Liz Carnabuci

VP & Managing Director Australasia & VP Diabetes Group APAC
Medtronic Australasia
 

Sustainability Solutions for MedTech

Day 3
10:34-11:04
Concurrent session
Due to safety and infection control requirements, packaging volumes in healthcare products are substantial, however, an increasing focus on delivering better sustainability solutions across all industries is driving the healthcare sector to better manage the issue of packaging whilst continuing to maintain vital safety standards.

In this session you about the latest advancements in waste reduction and innovative environmental solutions from leaders in the industry.
Aldin-Velic

Dr. Aldin Velic

General Manager, Southeast Asia
Oliver Healthcare Packaging
Paul Clark Headshot

Mr Paul Clark

Marketing & Sustainability Manager, IV Fluids, Medication Delivery, ANZ
Baxter Healthcare
Cortiula, Rebecca small

Ms Rebecca Cortiula

Senior Managing Director Australasia
Varian Medical Systems
 

The Flexible Workplace

Day 3
11:04-11:36
Concurrent session
  • Current research and benefits of flexible work offerings
  • Best practice examples of flexible work and the different programs on offer: return to work from parental leave, job sharing (*example of CEOs who job share), reduced hours, same hours with reduced days, summer leave policies, purchased leave, parental leave.
Deb Houston

Ms Debora Houston

Divisional Leader - Medical Device & Healthcare Technology
Tresp Recruitment
Jodi Adams Headshot

Ms Jodi Adams

Director, Human Resources
Medline
Alana Rodwell

Ms Alana Rodwell

HR Business Partner
Medline
 

Digital Health & the Future of Learning

Day 3
11:04-11:36
Concurrent session
With COVID-19 leading many companies to reconsider how they provide essential training to both specialists and internal teams, what does the future of education look like? Education about disease pathology and technical products is essential to delivering good patient outcomes and in this session we consider the future of VR, virtual training, augmented reality and how we can integrate these processes into the everyday running of our businesses.
Erik Maltais Headshot

Mr Erik Maltais

CEO & Co-Founder
Immertec
Sarah-Aitken

Dr Sarah Aitken

Vascular & Endovascular Surgeon, Concord Repatriation General Hospital and Clincial Academic
University of Sydney
Charlotte Hart Headshot

Ms Charlotte Hart

Senior Manager, Professional Education and Marketing
Nevro Australia
 

Dr Liz (Shoesmith) Wilson – Diversity & Inclusion 

Day 3
11:36-12:38
Combining her expertise in organisational transformation, a PhD in organisational culture and behaviour and passion for inclusion, Dr Elizabeth Wilson has set the global benchmark for inclusion and is creating a movement of change through organisations, governments and institutions. Dr Elizabeth Wilson is on a personal mission to create a world where everyone is included and valued for their difference. It was after indirectly experiencing the exclusion and discrimination of her husband, who is profoundly deaf, that she committed her career to inclusion. In fact, you may even recall her viral wedding video, which has amassed over 300-million views, of her using sign language to sing the song ‘1000 years’ to her husband before walking down the aisle in 2018.
Dr-Elizabeth-Shoesmith

Dr Liz (Shoesmith) Wilson

CEO & Founder
The Inclusive Organisation Group
Lauren barber

Ms Lauren Barber

Founder & Owner
NeedleCalm
Asset 15
demo-attachment-117-Path-18
demo-attachment-118-Path-19
demo-attachment-119-Path-948
Asset 16
demo-attachment-116-Path-17
Webinar-image

Three day broadcast

Watch the event live or on-demand

The MedTech20 conference will be completely virtual. Attendees will be able to ask questions, interact with presenters and more, all from the comfort of their home or office.

The new streaming service will give attendees the ability to watch any session at any time.